OAC
WST icon

OMERS Administration Corp’s West Pharmaceutical WST Stock Holding History

OMERS Administration Corp’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.2M Buy
12,769
+2,442
+24% +$608K 0.02% 384
2025
Q4 		$2.84M Buy
10,327
+7,684
+291% +$2.1M 0.02% 308
2025
Q3 		$693K Hold
2,643
– – 0.01% 652
2025
Q2 		$578K Hold
2,643
– – ﹤0.01% 625
2025
Q1 		$592K Sell
2,643
-435
-14% -$120K 0.01% 692
2024
Q4 		$1.01M Buy
3,078
+513
+20% +$161K 0.01% 525
2024
Q3 		$770K Hold
2,565
– – 0.01% 564
2024
Q2 		$845K Buy
+2,565
New +$906K 0.01% 569
2020
Q2 		– Sell
-3,500
Closed -$533K – 205
2020
Q1 		$533K Buy
+3,500
New +$539K 0.02% 121
2016
Q4 		– Sell
-2,900
Closed -$216K – 555
2016
Q3 		$216K Buy
+2,900
New +$230K ﹤0.01% 560

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return